Can Ozempic help lower your risk of dementia?

Translate to Spanish or other 102 languages!

According to Alzheimer’s Disease International, as of 2020, there were over 55 million peopleliving with dementia, with that number expected to rise to 78 million by 2030. Image for illustration purposes
According to Alzheimer’s Disease International, as of 2020, there were over 55 million peopleliving with dementia, with that number expected to rise to 78 million by 2030. Image for illustration purposes
- Advertisement -

Medical News Today

  • There are several risk factors for dementia, including type 2 diabetes and obesity. 
  • A new study reports that semaglutide — the active ingredient in GLP-1 medications Ozempic and Wegovy for type 2 diabetes and weight loss — may help lower dementia risk in people with type 2 diabetes. 
  • Researchers say semaglutide targets several dementia risk factors and is anti-inflammatory, which could explain this benefit to brain health.

According to Alzheimer’s Disease International, as of 2020, there were over 55 million peopleliving with dementia, with that number expected to rise to 78 million by 2030.

Follow the link below to Medical News Today to read the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/can-ozempic-weight-loss-diabetes-help-lower-risk-vascular-dementia?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-07-23&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -